Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after administration of GT-02287, suggest that GT-02287 may have the potential to slow ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...

A Streamlit app for predicting drug-target binding affinity using a trained CNN model. Input SMILES strings and protein sequences for fast and accurate predictions.

this year’s event will feature topics including applications of AI/ML within target identification and computational drug design, the impact of generative AI on ways of working and clinical updates ...

With a 63-48 victory over Bradley on Sunday, the Bulldogs became only the second team to win the Missouri Valley Conference’s ... victory with a commemorative poster from the Des Moines Register.

Forty years after his alleged involvement in the kidnapping, torture, and killing of a Drug Enforcement Administration ... at a Friday news conference. This included ordering the “kidnapping ...

Key Laboratory of Natural Products & Chemical Biology, Ministry of Education, Shandong University, Jinan 250012, P. R. China ...

HYDERABAD (Reuters) - The rising adoption of artificial intelligence in the pharmaceutical industry dominated discussions at a conference in India this week ... said it was piloting an AI model to ...

In the current study, the researchers used what is known as fragment-based drug design instead. The method involves first identifying a very small molecule that can bind to the target protein.

In the current study, the researchers used what is known as fragment-based drug design instead. The method involves first identifying a very small molecule that can bind to the target protein.

and the International Association for Axiomatic Design (IAAD). Since its first edition, ICAD conferences have been held in Cambridge and Worcester (MA-USA), Seoul and Daejeon (Korea), Lisbon (Portugal ...

SAE’s 2024 Injectable Drug Delivery conference brings together a complete big pharma speaker line-up providing technical updates on the relationship between drug product formulation and the ...